Quantification of the Quercetin Nanoemulsion Technique Using Various Parameters

Insights into selective behavior of NiFe2O4/graphene oxide@polyaniline nanocomposite as a novel adsorbent toward bioactive natural pigments

This research focuses on the selective adsorption capability of a synthesized graphene oxide-based magnetic nanocomposite, NiFe2O4/GO@PANI, specifically engineered for the capture of a group of structurally similar flavonoid pigments from organic/aqueous solutions. Various analytical techniques (including FT-IR, TGA, VSM, Zeta potential, BET, FE-SEM and EDX) were employed to elucidate the structural details of the nanocomposite, confirming the successful preparation of NiFe2O4/GO@PANI. Zeta potential analysis revealed a zeta pH of 7.3, consistent with the results obtained from pH optimization. Furthermore, VSM analysis effectively demonstrated the magnetic properties of the nanocomposite. Additionally, TGA results confirmed the thermal stability of the nanocomposite. Key parameters affecting adsorption such as solution pH, amount of adsorbent, exposure time, pigment concentration and temperature were systematically investigated. The results indicated high adsorption capacity (qe = 16300 μg/g) and selective affinity for quercetin compared to other flavonoid pigments such as naringenin, chrysin and daidzein. Kinetic and isotherm analyses revealed that the adsorption process closely follows the nonlinear pseudo-second-order kinetic model and the Nonlinear Freundlich isotherm. Furthermore, evaluation of the temperature effect confirmed a thermodynamically favorable adsorption process. Notably, regeneration tests confirmed the stability and reusability of the NiFe₂O₄/GO@PANI nanocomposite, which are essential for practical applications in natural pigment adsorption. The efficiency of synthesized nanocomposite toward quercetin in real samples such as yellow onion, red onion and red onion peel was also evaluated. This nanocomposite demonstrated an adsorption efficiency of 85.12 % (qe = 19823.4 μ g/g) for quercetin present in the red onion peel.

Multi-target mechanisms and potential applications of quercetin in the treatment of acne vulgaris

Acne vulgaris, a prevalent inflammatory dermatosis, afflicts approximately 90% of adolescents globally. Despite the efficacy of conventional therapies, including antibiotics and retinoids, their use is frequently limited by adverse effects and the emergence of drug resistance. Quercetin, a naturally occurring flavonoid, has garnered significant attention owing to its diverse biological activities, encompassing anti-inflammatory, antioxidant, antimicrobial, and immunomodulatory properties. This review comprehensively explores the multi-target mechanisms of quercetin in the treatment of acne, focusing on its ability to modulate inflammatory cytokine production, oxidative stress pathways, sebaceous gland activity, and microbial populations. Additionally, quercetin promotes skin barrier repair and reduces post-inflammatory hyperpigmentation and scarring through its antioxidant and anti-fibrotic effects. Despite promising in vitro and preclinical findings, challenges such as quercetin's low bioavailability and lack of robust clinical evidence necessitate further research. Advanced delivery systems, including nanoparticles and combination therapies, may optimize its therapeutic potential. This review provides insights into the molecular mechanisms and clinical applications of quercetin, highlighting its potential as a safe and effective alternative for acne management.

Design and Development of Dasatinib Nanoemulsions for Ocular Delivery: In vitro Characterization, Biocompatibility, and Ex vivo Ocular Irritation Study

Dasatinib, a potent tyrosine kinase inhibitor with dual anti-inflammatory and anti-angiogenic properties, holds significant potential for treating ocular diseases such as Corneal Neovascularization (CNV), uveitis, and diabetic retinopathy. However, its low aqueous solubility and limited ocular retention present major formulation challenges. This study concentrated on the design and evaluation of Dasatinib nanoemulsions (Dasa NEs) for ocular delivery, utilizing nanotechnology to enhance solubility, stability, and therapeutic efficacy. The Dasa NEs were prepared using Oleic acid (lipid phase), Tween 80, Propylene Glycol (PG) (Smix), with component ratios optimized through pseudo-ternary phase diagrams. The resulting formulations exhibited nanoscale droplet sizes (<100 nm), low polydispersity indices, and stable zeta potential, ensuring colloidal stability and efficient delivery. Comprehensive physicochemical evaluations confirmed that the NEs possessed ideal pH, refractive index, surface tension, and viscosity for ophthalmic applications. Biocompatibility assessments using the MTT assay on SIRC cells demonstrated high cell viability, while HET-CAM tests confirmed the absence of significant ocular irritation. In vitro diffusion studies indicated improved drug permeation, highlighting the potential for prolonged therapeutic effects. Stability studies further validated the robustness of the formulations under various conditions. The developed nanoemulsions offer a promising, non-invasive platform for ocular drug delivery, improving patient compliance and therapeutic outcomes. Future studies should focus on in vivo evaluations and long-term safety to advance the clinical translation of this novel formulation.

Polyphenols in Human Nutrition: European Regulations and Potential Classification as a Novel Food or Food Additive

Polyphenols are widely present in botanicals and are partially responsible for the health benefits associated with plant-based diets. Due to their nutritional and health-promoting properties, polyphenols are increasingly being proposed as innovative food ingredients, whether for technological applications or for inclusion in food supplements and other food products to enhance health. However, the regulatory considerations surrounding the use of polyphenols in human nutrition are critical. Although polyphenols are routinely consumed through fruits and vegetables, in Europe, polyphenols and plant extracts can be classified as novel foods or food additives. The scientific evaluation conducted by the European Food Safety Authority (EFSA) to obtain the necessary authorizations is stringent, requiring a substantial level of evidence to ensure the safe use of polyphenols. This work aims to provide an overview of the current European regulatory frameworks for novel foods and food additives and to discuss the scientific requirements for the approval of pure polyphenols and polyphenol-rich botanical extracts in Europe.

Addressing overlooked design considerations for nanoemulsions

Despite progress in genetic and molecular research, which has opened up a myriad of targeted therapeutic possibilities, the compromised solubility and absorption profile of therapeutic entities restrict their passage across lipid barriers compromising efficacy. Consequently, nanoemulsions accrued significance as futuristic, safe, and effective lipid-based drug delivery systems due to their inherent array of physicochemical properties and provide exquisite bioavailability, reduced toxicity, and improved solubility of hydrophobic entities based on size and surface area. However, a pronounced gap exists in understanding and addressing challenges that arise during design and development of nanoemulsions. In this context, we have attempted to reconsider overlooked aspects of nanoemulsion design, offering insight into its commercial viability.

Novel griseofulvin zinc nanohybrid emulsion for intensifying the antimicrobial control of dermatophytes and some opportunistic pathogens

Dermatophytosis is a critical sort of skin infection caused by dermatophytes. The long-term treatment of such skin infections may be improved through the application of nanotechnology. This study aimed to prepare griseofulvin zinc Nanohybrid emulsion (GF-Zn-NHE) to improve griseofulvin activity against dermatophytes and some opportunistic pathogenic yeasts and bacteria. The GF-Zn-NHE is prepared by ultra-homogenization ultra-sonication strategies and validated by UV-visible spectroscopy analysis that confirms presences of griseofulvin and Zn-NPs peaks at 265 and 360 nm, respectively. The GF-Zn-NHE has mean distribution size 50 nm and zeta potential in the range from -40 to -36 mV with no significant changes in size distribution and particle size within 120 day ageing. Fourier transform infrared spectroscopy spectrum confirmed the presence of griseofulvin and Zn-NPs stretching vibration peaks. Gamma ray has a negative influence on GF-Zn-NE production and stability. GF-Zn-NHE drug release 95% up to 24 h and 98% up to 72 h of GF was observed and Zinc 90% up to 24 h and 95% up to 72 h, respectively. High antimicrobial activity was observed with GF-Zn-NHE against dermatophytic pathogens in compare with GF, GF-NE, zinc nitrate and ketoconazole with inhibition zone ranged from 14 to 36 mm. The results have shown that the MIC value for Cryptococcus neoformans, Prophyromonas gingivalis and Pseudomonas aeruginosa is 0.125 mg ml -1 and for Trichophyton rubrum, L. bulgaricus and Escherichia coli value is 0.25 mg ml -1 and for Candida albicans, Malassezia furfur and Enterococcus faecalis is 0.5 mg ml -1 and finally 1 mg ml -1 for Streptococcus mutans. TEM of treated Cryptococcus neoformans cells with GF-Zn-NHE displayed essentially modified morphology, degradation, damage of organelles, vacuoles and other structures.

Luteolin as a potential therapeutic candidate for lung cancer: Emerging preclinical evidence

Lung cancer is a prevalent malignant tumor and a leading cause of cancer-related fatalities globally. However, current treatments all have limitations. Therefore, there is an urgent need to identify a readily available therapeutic agent to counteract lung cancer development and progression. Luteolin is a flavonoid derived from vegetables and herbs that possesses preventive and therapeutic effects on various cancers. With the goal of providing new directions for the treatment of lung cancer, we review here the recent findings on luteolin so as to provide new ideas for the development of new anti-lung cancer drugs. The search focused on studies published between January 1995 and January 2024 that explored the use of luteolin in lung cancer. A comprehensive literature search was conducted in the SCOPUS, Google Scholar, PubMed, and Web of Science databases using the keywords "luteolin" and "lung cancer." By collecting previous literature, we found that luteolin has multiple mechanisms of therapeutic effects, including promotion of apoptosis in lung cancer cells; inhibition of tumor cell proliferation, invasion and metastasis; and modulation of immune responses. In addition, it can be used as an adjuvant to radio-chemotherapy and helps to ameliorate cancer complications. This review summarizes the structure, natural sources, physicochemical properties and pharmacokinetics of luteolin, and focuses on the anti-lung cancer mechanism of luteolin, so as to provide new ideas for the development of new anti-lung cancer drugs.

O1/W/O2 double emulsion gels based on nanoemulsions and Pickering particles for co-encapsulating quercetin and cyanidin: A functional fat substitute

An O1/W/O2 double emulsion gel, as a functional fat substitute and based on nanoemulsions and hydrophobic Pickering particles, is prepared by two-step emulsification to co-encapsulate hydrophilic cyanidin and hydrophobic quercetin. Nanoemulsions loading quercetin are fabricated by Tween-80 and combining high-speed and high-pressure emulsification. Phytosterol nanoparticles stabilize the W-O2 interface of the secondary emulsion to load cyanidin in the W phase. The concentration of Tween-80 is optimized as 0.3% by the droplet size and viscosity of nanoemulsions. The structural stability of double emulsion gels will be weakened along with the increase of nanoemulsions, showing lower modulus and encapsulation efficiency (EE) and bigger droplets. In double emulsion gels, the EE of quercetin and cyanidin reaches 93% and 85.6%, respectively. Analysis of molecular interaction indicates that Tween-80 would decrease the in-situ hydrophobicity of phytosterol nanoparticles by hydrogen bonding adsorption, thereby weakening the emulsification. The pH-chromic 3D printing of double emulsion gels is designed according to the pH sensitivity of cyanidin. Texture profile analysis is performed to test the textural properties of 3D-printed objects. The simulated digestion is conducted on double emulsion gels. The double emulsion gel with fewer nanoemulsions is beneficial for protecting quercetin and improving the delivery due to the higher structural stability, while that with more nanoemulsions is conducive to the digestion of cyanidin and camellia oil due to weakened semi-solid properties. This double emulsion gel further simulates fat tissues by co-encapsulating hydrophilic and hydrophobic substances, promoting the application of fat substitutes in the food industry.

Effectiveness of a formulation based on Ocimum gratissimum essential oil and cashew gum as inhibitors of quality loss and melanosis in shrimp

In this study, two nanoemulsions were formulated with essential oil (EO) of Ocimum gratissimum with (EON) or without (EOE) cashew gum (CG). Subsequently, inhibition of melanosis and preservation of the quality of shrimp stored for 16 days at 4 ± 0.5 °C were evaluated. A computational approach was performed to predict the system interactions. Dynamic light scattering (DLS) and atomic force microscopy (AFM) were used for nanoparticle analysis. Gas chromatography and flame ionization detector (GC-FID) determined the chemical composition of the EO constituents. Shrimps were evaluated according to melanosis's appearance, psychrotrophic bacteria's count, pH, total volatile basic nitrogen, and thiobarbituric acid reactive substances. EON exhibited a particle size three times smaller than EOE. The shrimp treated with EON showed a more pronounced sensory inhibition of melanosis, which was considered mild by the 16th day. Meanwhile, in the other groups, melanosis was moderate (EOE) or severe (untreated group). Both EON and EOE treatments exhibited inhibition of psychrotrophic bacteria and demonstrated the potential to prevent lipid oxidation, thus extending the shelf life compared to untreated fresh shrimp. EON with cashew gum, seems more promising due to its physicochemical characteristics and superior sensory performance in inhibiting melanosis during shrimp preservation.

Silk Fibroin Formed Bioadhesive Ophthalmic Gel for Dry Eye Syndrome Treatment

PURPOSE

Dry eye syndrome (DES), arising from various etiologic factors, leads to tear film instability and ocular surface damage. Given its anti-inflammatory effects, cyclosporine A (CsA) has been widely used as a short-term treatment option for DES. However, poor bioavailability and solubility of CsA in aqueous phase make the development of a cyclosporine A-based eye drop for ocular topical application a huge challenge.

METHODS

In this study, a novel strategy for preparing cyclosporine A-loaded silk fibroin nanoemulsion gel (CsA NBGs) was proposed to address these barriers. Additionally, the rheological properties, ocular irritation potential, tear elimination kinetics, and pharmacodynamics based on a rabbit dry eye model were investigated for the prepared CsA NBGs. Furthermore, the transcorneal mechanism across the ocular barrier was also investigated.

RESULTS

The pharmacodynamics and pharmacokinetics of CsA NBGs exhibited superior performance compared to cyclosporine eye drops, leading to a significant enhancement in the bioavailability of CsA NBGs. Furthermore, our investigation into the transcorneal mechanism of CsA NBGs revealed their ability to be absorbed by corneal epithelial cells via the paracellular pathway.

CONCLUSION

The CsA NBG formulation exhibits promising potential for intraocular drug delivery, enabling safe, effective, and controlled administration of hydrophobic drugs into the eye. Moreover, it enhances drug retention within the ocular tissues and improves systemic bioavailability, thereby demonstrating significant clinical translational prospects.

Plant-based essential oil encapsulated in nanoemulsions and their enhanced therapeutic applications: An overview

In recent years, studies on the formulation of nanoemulsions have been the focus of attention due to their potential applicability in food, pharmaceuticals, cosmetics, and agricultural industries. Nanoemulsions can be formulated using ingredients approved by the Food and Drug Administration (FDA), which assures their safety profiles to a great extent. Bioactive compounds such as essential oils although have strong biological properties and antimicrobial compounds, their usage is restricted due to their high volatility, instability, and hydrophobic nature. Therefore, nanoemulsion as carrier vehicle can be used to encapsulate essential oils to obtain stable and enhanced physicochemical characteristics of the essential oils. This review details the structure, formulation, and characterization techniques used for nanoemulsions, with a focus on the essential oil-based nanoemulsions which have the potential to be used as antimicrobial and anticancer therapeutics.

Quercetin: A Potential Polydynamic Drug

The study of natural products as potential drug leads has gained tremendous research interest. Quercetin is one of those natural products. It belongs to the family of flavonoids and, more specifically, flavonols. This review summarizes the beneficial pharmaceutical effects of quercetin, such as its anti-cancer, anti-inflammatory, and antimicrobial properties, which are some of the quercetin effects described in this review. Nevertheless, quercetin shows poor bioavailability and low solubility. For this reason, its encapsulation in macromolecules increases its bioavailability and therefore pharmaceutical efficiency. In this review, a brief description of the different forms of encapsulation of quercetin are described, and new ones are proposed. The beneficial effects of applying new pharmaceutical forms of nanotechnology are outlined.

Fabrication and Biological Activities of All-in-One Composite Nanoemulsion Based on Blumea balsamifera Oil-Tea Tree Oil

Nanoemulsion is a new multi-component drug delivery system; the selection of different oil phases can give it special physiological activity, and play the role of "medicine and pharmaceutical excipients all-in-one". In this paper, we used glycyrrhizic acid as the natural surfactant, and Blumea balsamifera oil (BB) and tea tree oil (TTO) as the mixed oil phase, to obtain a new green functional composite nanoemulsion. Using the average particle size and polydispersion index (PDI) as the evaluation criteria, the effects of the oil ratio, oil content, glycyrrhizic acid concentration, and ultrasonic time on the nanoemulsion were systematically investigated. The stability and physicochemical properties and biological activities of BB-TTO NEs prepared via the optimum formulation were characterized. The optimal prescription was BB: TTO = 1:1, 5% oil phase, 0.7% glycyrrhizic acid, and 5 min ultrasonication time. The mean particle size, PDI, and zeta potential were 160.01 nm, 0.125, and -50.94 mV, respectively. The nanoemulsion showed non-significant changes in stability after centrifugation, dilution, and 120 days storage. These nanoemulsions were found to exhibit potential antibacterial and anti-inflammatory activities. The minimal inhibitory concentration (MIC) of BB-TTO NEs against Escherichia coli, Staphylococcus aureus, and Pseudomonas aeruginosa is 2975 μg/mL, 2975 μg/mL, and 5950 μg/mL, respectively. A lower level of inflammatory cell infiltration and proportion of fibrosis were found in the synovial tissue of AIA rats treated with BB-TTO NEs. These findings demonstrate that the BB-TTO NEs produced in this study have significant potential for usage in antibacterial and anti-inflammatory areas.